0001140361-18-020306.txt : 20180427
0001140361-18-020306.hdr.sgml : 20180427
20180427193208
ACCESSION NUMBER: 0001140361-18-020306
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180322
FILED AS OF DATE: 20180427
DATE AS OF CHANGE: 20180427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 18786236
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2018-03-22
2018-03-26
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001238403
SPIEGELMAN DANIEL K
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2018-03-22
2018-03-22
4
F
0
3598
81.36
D
73587
D
This amendment is being filed solely to correct an administrative error in the original filing regarding the number of shares reported as forfeited.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2018-04-27